Probiotics Market Comprehensive Statistics, Growth Rate, and Future Trends 2035

The global probiotics market size is estimated to be $70.9 billion in 2024 and is projected to reach $165.1 billion by 2035. The market is anticipated to grow at a CAGR of 8.0%, during the forecast period till 2035.

Probiotics are gut-friendly microorganisms (bacteria and yeast) that confer various health benefits in the consumers, wherein they improve gut health and thus support in treating irritable bowel syndrome and antibiotic-induced diarrhea. Probiotic products comprise of approximately 1 to 10 billion colony forming units (CFUs) of viable microbial strains so as to generate the desired positive effect in the body, upon consumption. These bacteria act as a potential barrier to the pathogenic bacteria in the body and regulates the immune cells in the body to fight the infection. Driven by the potential benefits of probiotics, there has been a surge in the research and development of novel probiotic products that can fulfil nutritional and / or clinical supplementation requirements. Through their metabolic and immunomodulatory actions, probiotics help prevent several health ailments, such as obesity, food allergies, diabetes, eczema and cancer. Notably, probiotics are now widely recognized as mainstream wellness products amongst the health-conscious population.

Live probiotic strains when formulated in dosage formats, such as tablets, capsules and powders, are considered as health supplements. These supplements can either be designed to target specific diseases or to maintain general health. Examples include nutritional supplements, specialty supplements and infant formula. In addition, various functional foods and beverages (containing probiotics) are consumed on a regular basis by the consumers, owing to its taste, texture and ease of incorporation in daily meals. These include fermented foods, baked foods, chocolates, dried foods, fermented drinks, dairy and non-dairy products. Up lately, the pharmaceutical industry is extensively engaged in the development of advanced forms of probiotics, also known as next-generation probiotics. These probiotics can reduce oxidative stress, modulate the inflammatory pathways and prevent neurodegenerative diseases. Unlike traditional probiotics, these advanced products will have the potential in alleviating chronic human ailments, such as cancer through apoptosis induction, cytokine upregulation and exclusion of carcinogens. In pursuit of gaining a competitive edge, industry stakeholders are actively innovating and developing novel probiotics that can be consumed by various human population

The primary purpose of this analysis was to develop a better understanding of the overall potential and capabilities of different companies having probiotic portfolio. It is worth highlighting that the input data used for this analysis was collated from publicly available sources. Further, at no point should the inferences presented in this section be construed as a recommendation that one company is better than another.

The following approach was adopted to compare the key probiotic companies in the market:

·         As a starting point, we collated information on the aforementioned parameters for key companies that are involved in the offering probiotics, and thus, were considered for this analysis. 

·         The probiotic companies were segregated across three peer groups based on their company size, including mid-sized, large and very large companies.

Further, company competitiveness was assessed score for companies using company strength (in terms of number of years since its establishment) and portfolio strength (based on number of probiotic brands, type of probiotic, target human population, end user and type of ingredient).

Thank you for reading our report. Kindly get in touch with us to know more about the report or to receive a customized copy of it. Our team will ensure the report is tailored according to your needs. 

To view more details on this report, click on the link

https://www.rootsanalysis.com/reports/probiotics-market.html

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.                   

We specialise in analysing areas which have lacked quality research so far or require more focused understanding within the broader industry. All our reports are structured in a way to enable the reader develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we also provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

The research efforts are driven by a global team. The leadership team brings a wealth of experience within the sector. Their collective experience in pharmaceutical / affiliated domains allows us to tackle various areas of research in a structured way. We also regularly leverage our global network of experts who hold senior leadership positions in reputed firms and organisations worldwide.

Contact:

Roots Analysis

Gaurav Chaudhary

+1 (415) 800 3415

+44 (122) 391 1091

Gaurav.chaudhary@rootsanalysis.com

Website: https://www.rootsanalysis.com/